CEO of Avadel Pharmaceuticals Plc (30-Year Financial, Insider Trades) Gregory J Divis (insider trades) bought 13,000 shares of AVDL on 08/12/2020 at an average price of $7.78 a share. The total cost of this purchase was $101,140.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber. Avadel Pharmaceuticals PLC has a market cap of $449.470 million; its shares were traded at around $7.72 with a P/E ratio of 48.25 and P/S ratio of 6.93. GuruFocus has detected 3 severe warning signs with Avadel Pharmaceuticals PLC. .
CEO Recent Trades:
-
CEO Gregory J Divis bought 13,000 shares of AVDL stock on 08/12/2020 at the average price of $7.78. The price of the stock has decreased by 0.77% since.
Directors and Officers Recent Trades:
-
Director Eric J Ende bought 15,000 shares of AVDL stock on 08/12/2020 at the average price of $7.76. The price of the stock has decreased by 0.52% since.
For the complete insider trading history of AVDL, click here
.This article first appeared on GuruFocus.